Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Adar1 Capital Management, Llc

10% Owner at InMed Pharmaceuticals Inc. (INM); 10% Owner at NextCure, Inc. (NXTC); 10% Owner at Rallybio Corp (RLYB); 10% Owner at Tenax Therapeutics, Inc. (TENX)

Purchase track record

Above average. Based on 2 purchases with a full 90 days of price history.

67
Avg. 90-day return+14.6%
vs. S&P 500+10.6%
Beat the market100%
Paper profit on buys+$1.1M
Total bought / sold$4.3M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Oct 8SEC INMInMed Pharmaceuticals Inc. Buy 5,601940,622 held (+1%) $1.33 $7K +2.4%
Oct 8SEC INMInMed Pharmaceuticals Inc. Buy 3,046943,668 held (+0%) $1.33 $4K +2.3%
Oct 8SEC INMInMed Pharmaceuticals Inc. Buy 2,256945,924 held (+0%) $1.33 $3K +2.4%
Oct 5SEC INMInMed Pharmaceuticals Inc. Buy 16,431908,532 held (+2%) $1.33 $22K +2.3%
Oct 5SEC INMInMed Pharmaceuticals Inc. Buy 8,307916,839 held (+1%) $1.33 $11K +2.3%
Oct 5SEC INMInMed Pharmaceuticals Inc. Buy 18,182935,021 held (+2%) $1.33 $24K +2.3%
Sep 8SEC TENXTenax Therapeutics, Inc. Buy 900,0006,524,151 held (+16%) $1.78 $1.6M +5.1%
Aug 3SEC NXTCNextCure, Inc. Buy 50,000443,266 held (+13%) $4.97 $248K +44.5%
Aug 3SEC NXTCNextCure, Inc. Buy 20,000463,266 held (+5%) $5.00 $100K +43.6%
Aug 3SEC NXTCNextCure, Inc. Buy 20,000483,266 held (+4%) $5.00 $100K +43.6%
Aug 3SEC NXTCNextCure, Inc. Buy 25,000508,266 held (+5%) $4.81 $120K +49.3%
Aug 3SEC NXTCNextCure, Inc. Buy 100,000608,266 held (+20%) $4.90 $490K +46.5%
Aug 3SEC NXTCNextCure, Inc. Buy 77,850686,116 held (+13%) $4.96 $386K +44.8%
Aug 3SEC NXTCNextCure, Inc. Buy 3,300689,416 held (+0%) $4.98 $16K +44.2%
Aug 3SEC NXTCNextCure, Inc. Buy 25,000714,416 held (+4%) $4.98 $124K +44.2%
Aug 3SEC NXTCNextCure, Inc. Buy 8,003722,419 held (+1%) $4.80 $38K +49.6%
Jul 29SEC NXTCNextCure, Inc. Buy 7,798383,456 held (+2%) $5.00 $39K +43.6%
Jul 29SEC NXTCNextCure, Inc. Buy 6,400389,856 held (+2%) $4.95 $32K +45.1%
Jul 29SEC NXTCNextCure, Inc. Buy 1,810391,666 held (+0%) $5.00 $9K +43.6%
Jul 29SEC NXTCNextCure, Inc. Buy 1,600393,266 held (+0%) $5.00 $8K +43.6%
Jul 17SEC INMInMed Pharmaceuticals Inc. Buy 1,000801,000 held (+0%) $1.56 $2K -12.8%
May 20SEC RLYBRallybio Corp Buy 6,009916,152 held (+1%) $13.98 $84K +21.7%
May 20SEC RLYBRallybio Corp Buy 10,000926,152 held (+1%) $13.98 $140K +21.7%
May 20SEC RLYBRallybio Corp Buy 200926,352 held (+0%) $13.80 $3K +23.3%
May 13SEC RLYBRallybio Corp Buy 5,100784,884 held (+1%) $14.00 $71K +21.6%
May 13SEC RLYBRallybio Corp Buy 25,000809,884 held (+3%) $14.00 $350K +21.6%
May 13SEC RLYBRallybio Corp Buy 19,900829,784 held (+2%) $14.00 $279K +21.6%
May 13SEC RLYBRallybio Corp Buy 800830,584 held (+0%) $13.83 $11K +23.1%
  • Buy

    10% Owner Adar1 Capital Management, Llc bought $22K of INM at $1.33 — largest purchase by this insider in our records.

  • Buy

    10% Owner Adar1 Capital Management, Llc bought $24K of INM at $1.33 — largest purchase by this insider in our records.

  • Buy

    10% Owner Adar1 Capital Management, Llc bought $1.6M of TENX at $1.78 — first open-market purchase in our records.

  • Buy

    10% Owner Adar1 Capital Management, Llc bought $248K of NXTC at $4.97 — largest purchase by this insider in our records.

  • Buy

    10% Owner Adar1 Capital Management, Llc bought $490K of NXTC at $4.90 — largest purchase by this insider in our records.

  • Buy

    10% Owner Adar1 Capital Management, Llc bought $39K of NXTC at $5.00 — first open-market purchase in our records.